Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Plunkett

Showing results (71-80 of 244) with videos related to

Pageof 25
Sort By:
Haematology and Blood Transfusion|January 1, 1990
Pharmacologically directed design of leukemia therapyW Plunkett, V Heinemann, E Estey, et al.
Family and Consumer Sciences Research Journal|January 22, 2024
Life Quality of University Students From Immigrant Families in the United StatesFarin Bakhtiari, Aprile D Benner, Scott W Plunkett
Journal of Health Psychology|May 5, 2018
Factor structure and validity of the Affective Style QuestionnaireRui Jiang, Scott W Plunkett, Andrew T Ainsworth
Molecular Pharmacology|March 22, 2001
2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine: a novel anticancer nucleoside analog that causes both DNA strand breaks and G(2) arrestA Azuma, P Huang, A Matsuda, et al.
Molecular Pharmacology|July 1, 1981
Metabolism of 9-beta-D-xylofuranosyladenine by the Chinese hamster ovary cellB A Harris, P P Saunders, W Plunkett
Cancer Research|August 15, 1991
Plasma and cerebrospinal fluid pharmacokinetics of 1-beta-D-arabinofuranosylcytosine and 1-beta-D-arabinofuranosyluracil following the repeated intravenous administration of high- and intermediate-dose 1-beta-D-arabinofuranosylcytosineL E Damon, W Plunkett, C A Linker
Cancer Investigation|January 1, 1990
Cytotoxicity and antitumor activity of 2',2'-difluorodeoxycytidine (Gemcitabine)G B Grindey, L W Hertel, W Plunkett
Biochemical Pharmacology|May 30, 2001
Cellular pharmacokinetics and pharmacodynamics of the deoxycytidine analog 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine (CNDAC)A Azuma, P Huang, A Matsuda, et al.
Cancer Research|November 1, 1985
Relationship of 1-beta-D-arabinofuranosylcytosine in plasma to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate levels in leukemic cells during treatment with high-dose 1-beta-D-arabinofuranosylcytosineJ O Liliemark, W Plunkett, D O Dixon
Cancer Chemotherapy and Pharmacology|January 1, 1986
9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate pharmacokinetics in plasma and tumor cells of patients with relapsed leukemia and lymphomaL Danhauser, W Plunkett, M Keating, et al.
Pageof 25

Showing results (71-80 of 244) with videos related to

Sort By:
Pageof 25
Haematology and Blood Transfusion|January 1, 1990
Pharmacologically directed design of leukemia therapyW Plunkett, V Heinemann, E Estey, et al.
Family and Consumer Sciences Research Journal|January 22, 2024
Life Quality of University Students From Immigrant Families in the United StatesFarin Bakhtiari, Aprile D Benner, Scott W Plunkett
Journal of Health Psychology|May 5, 2018
Factor structure and validity of the Affective Style QuestionnaireRui Jiang, Scott W Plunkett, Andrew T Ainsworth
Molecular Pharmacology|March 22, 2001
2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine: a novel anticancer nucleoside analog that causes both DNA strand breaks and G(2) arrestA Azuma, P Huang, A Matsuda, et al.
Molecular Pharmacology|July 1, 1981
Metabolism of 9-beta-D-xylofuranosyladenine by the Chinese hamster ovary cellB A Harris, P P Saunders, W Plunkett
Cancer Research|August 15, 1991
Plasma and cerebrospinal fluid pharmacokinetics of 1-beta-D-arabinofuranosylcytosine and 1-beta-D-arabinofuranosyluracil following the repeated intravenous administration of high- and intermediate-dose 1-beta-D-arabinofuranosylcytosineL E Damon, W Plunkett, C A Linker
Cancer Investigation|January 1, 1990
Cytotoxicity and antitumor activity of 2',2'-difluorodeoxycytidine (Gemcitabine)G B Grindey, L W Hertel, W Plunkett
Biochemical Pharmacology|May 30, 2001
Cellular pharmacokinetics and pharmacodynamics of the deoxycytidine analog 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine (CNDAC)A Azuma, P Huang, A Matsuda, et al.
Cancer Research|November 1, 1985
Relationship of 1-beta-D-arabinofuranosylcytosine in plasma to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate levels in leukemic cells during treatment with high-dose 1-beta-D-arabinofuranosylcytosineJ O Liliemark, W Plunkett, D O Dixon
Cancer Chemotherapy and Pharmacology|January 1, 1986
9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate pharmacokinetics in plasma and tumor cells of patients with relapsed leukemia and lymphomaL Danhauser, W Plunkett, M Keating, et al.
Pageof 25